I’m still not convinced that having Ma’s in the role is going to be doing much for us unless she is responsible for negotiating the acquisition. From a day-to-day perspective, I do not believe that Missling is giving up any control, and that things will proceed business as usual for the foreseeable future. Remember, Missling has always stated that they will become big Pharma and partner Alzheimer’s, and Parkinson’s and keep the rare disease business for themselves. so I don’t believe Ma’s is in position for anything to happen in the short term maybe five years from now yes.
Market Data 
Markets 
AI
